Literature DB >> 12546341

Increased matrix metalloproteinase-9 with elastolysis in nocturnal asthma.

David N Pham1, Hong Wei Chu, Richard J Martin, Monica Kraft.   

Abstract

BACKGROUND: Matrix metalloproteinase-9 (MMP-9) is capable of degrading elastin, whereas tissue inhibitor of metalloproteinase-1 (TIMP-1) can inhibit MMP-9 activity. We observed reduced airway tissue elastin volume density in six subjects with nocturnal asthma (NA) as compared with seven subjects with nonnocturnal asthma (NNA) and seven normal controls (NL) when endobronchial biopsies were evaluated morphometrically at 4:00 PM and 4:00 AM.
OBJECTIVE: We hypothesized that increased metalloproteinases and decreased tissue inhibitors of metalloproteinases in the airways of subjects with NA may be responsible for reduced elastin volume density.
METHODS: Ten additional subjects with NA, 10 subjects with NNA, and 7 normal control subjects underwent bronchoscopy with bronchoalveolar lavage at 4:00 PM and 4:00 AM. Levels of MMP-2, MMP-9, TIMP-1, and TIMP-2 were determined in bronchoalveolar lavage by enzyme-linked immunosorbent assay.
RESULTS: There was a fourfold circadian increase in bronchoalveolar lavage levels of MMP-9, and there was a twofold increase in MMP-9:TIMP-1 ratio in NA subjects from 4:00 PM to 4:00 AM. There were no circadian changes in the NNA and NL subjects. At 4:00 AM, MMP-9 levels and the MMP-9:TIMP-1 ratio were highest in NA subjects. At 4:00 PM, no significant group differences were observed. The MMP-9 levels positively correlated with the overnight fall in forced expiratory volume in 1 second and the MMP-9/TIMP-1 ratio negatively correlated with the 4:00 AM % predicted forced expiratory volume in 1 second.
CONCLUSIONS: Our results from these two pilot studies suggest that increased MMP-9 and decreased TIMP-1 at night in NA may lead to reduced elastin density.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12546341     DOI: 10.1016/S1081-1206(10)63617-4

Source DB:  PubMed          Journal:  Ann Allergy Asthma Immunol        ISSN: 1081-1206            Impact factor:   6.347


  5 in total

1.  Role of Matrix Metalloproteinases-1 and -2 in Interleukin-13-Suppressed Elastin in Airway Fibroblasts in Asthma.

Authors:  Jennifer L Ingram; David Slade; Tony D Church; Dave Francisco; Karissa Heck; R Wesley Sigmon; Michael Ghio; Anays Murillo; Rafael Firszt; Njira L Lugogo; Loretta Que; Mary E Sunday; Monica Kraft
Journal:  Am J Respir Cell Mol Biol       Date:  2016-01       Impact factor: 6.914

2.  Interleukin-13 induces collagen type-1 expression through matrix metalloproteinase-2 and transforming growth factor-β1 in airway fibroblasts in asthma.

Authors:  Rafael Firszt; Dave Francisco; Tony D Church; Joseph M Thomas; Jennifer L Ingram; Monica Kraft
Journal:  Eur Respir J       Date:  2013-05-16       Impact factor: 16.671

3.  A multivariate analysis of risk factors for the air-trapping asthmatic phenotype as measured by quantitative CT analysis.

Authors:  Ashley Busacker; John D Newell; Thomas Keefe; Eric A Hoffman; Janice Cook Granroth; Mario Castro; Sean Fain; Sally Wenzel
Journal:  Chest       Date:  2008-08-08       Impact factor: 9.410

4.  Effect of a matrix metalloproteinase-12 inhibitor, S-1, on allergic airway disease phenotypes in mice.

Authors:  Yingyan Yu; Yoshihiko Chiba; Hiroyasu Sakai; Miwa Misawa
Journal:  Inflamm Res       Date:  2010-01-12       Impact factor: 4.575

5.  Long-term use of doxycycline can improve chronic asthma and possibly remodeling: the result of a pilot observation.

Authors:  Parthasarathi Bhattacharyya; Rantu Paul; Partha Bhattacharjee; Arko Ghosh; Ratna Dey; Malabika Ghosh; Madan Sharma
Journal:  J Asthma Allergy       Date:  2012-08-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.